Cabaletta Bio Inc. (NASDAQ:CABA) currently has a daily average trading volume of 1.55M but it saw 311133 shares traded on Wednesday. With a market cap of 94.29M USD, stock’s current market price of $3.53 came falling about -1.67 while comparing to the previous closing price of $3.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.24 and as low as $0.59. In the recent trading on the day, stock has struck highest price mark of $3.68 while lowest mark touched by it was $3.32.
Taking a look at 20-day trading activity of Cabaletta Bio Inc. (CABA) gives us an average price of $2.64, while its current price level is -73.34% below from 52-week high level whereas it is 498.31% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.61 while that of 200 days or SMA-200 reads an average of $1.58. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.16% during that period while stretching the period over a month that increases to 16.12%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 67.44 which implies that the stock is in neutral territory.
The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $3.00 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $12.00. Average price target assigned by them is $7.83 which highlights an upside potential of 54.92% for the stock over that period. And to attain the median price target of $8.50 assigned by those analysts, stock has to add about 58.47% of value to its current levels.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which downgraded the stock as “Equal-Weight” in its note to investors issued on August 30, 2022, recommending a price target of between $15 and $3 for it. Morgan Stanley issued its recommendations for the stock as it resumed the price target for the stock is $20.
Over the week, CABA’s stock price is moving -6.61% down while it is 97.76% when we observe its performance for the past one month. Year-to-date it is -6.86% down and over the past year, the stock is showing a downside performance of -67.94%.
The latest quarterly earnings report issued by the company was for quarter ended 6/29/2022, when its quarterly earnings per share (EPS) of -$0.45 beat the consensus estimate of -$0.5 for the same. For CABA, analysts are forecasting an EPS-growth rate of 1.70% for current year and estimate for EPS growth in next year is 12.40%.
Currently, Cabaletta Bio Inc.’s total number of outstanding shares is 29.01M with 4.31% of that held by the insiders while 63.01% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -50.40%. Stock has a price to book (P/B) ratio of 1.19. Its return on asset (ROA) is -47.20% on average.